Zalicus Inc. to Present at the 2012 JMP Securities Healthcare Conference
Published: Jul 06, 2012
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus Inc. (NASDAQ: ZLCS), a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that Zalicus management will present at the 2012 JMP Securities Healthcare Conference at 10:00 a.m. ET on Thursday, July 12, 2012 at the Peninsula Hotel in New York. Interested parties may access a live webcast of the presentation by visiting the Zalicus website at www.zalicus.com. The webcast will be archived on the Zalicus website following the event.